Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment
Authors:
- 8 June 2017
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 27 (1) , 120-123
Abstract
Objective: There is a decreased risk of breast cancer in systemic lupus erythematosus (SLE) versus the general population; little is known regarding the receptor status of breast cancers in SLE, or treatment. Methods: Breast cancer cases occurring after SLE diagnosis were ascertained through linkage with tumor registries. We determined breast cancer positivity for estrogen receptors (ER), progesterone receptors (PR), and/or Human Epidermal Growth Factor Receptor 2 (HER2), as well as cancer treatment. Results: We obtained information on ER, PR, and/or HER2 status for 63 SLE patients with breast cancer. Fifty-three had information on ER and/or PR status; 36 of these (69%) were ER positive. Thirty-six of the 63 had information on HER2 status; of these, 26 had complete information on all three receptors. Twenty-one of these 26 (81%) were HER2 negative; seven of 26(27%) were triple negative. All but one patient underwent surgery; 11.5% received both non-tamoxifen chemotherapy and radiotherapy, 16.4% radiotherapy without non-tamoxifen chemotherapy, and 14.7% received non-tamoxifen chemotherapy without radiotherapy. Conclusion: ER positivity was similar to historical general population figures, with a trend toward a higher proportion of triple-negative breast cancers in SLE (possibly reflecting the relatively young age of our SLE patients).Keywords
This publication has 7 references indexed in Scilit:
- Cancer risk in systemic lupus: An updated international multi-centre cohort studyJournal of Autoimmunity, 2013
- Cancer treatment and survivorship statistics, 2012CA: A Cancer Journal for Clinicians, 2012
- Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysisBritish Journal of Cancer, 2011
- Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control studyBritish Journal of Cancer, 2009
- Toxicity of radiotherapy in patients with collagen vascular diseaseCancer, 2008
- Role of radiation therapy in patients with a diagnosis of both systemic lupus erythematosus and cancerArthritis Care & Research, 2005
- Matched-Control Retrospective Study of the Acute and Late Complications in Patients with Collagen Vascular Diseases Treated with Radiation TherapyThe Cancer Journal, 2003